[1] 马晓莉,赵军阳,金眉,等.北京儿童医院视网膜母细胞瘤3年诊断治疗效果总结[J].中华实用儿科临床杂志,2014,29(15):1141-1144. [2] Achyut N P.Retinoblastoma: an overview[J].Saudi J Ophthalmol,2014,28(4):310-315. [3] Jehanne M, Brisse H,Gauthier-Villars M,et al.Retinoblastoma:recent advances[J].Bull Cancer,2014,101(4):380-387. [4] Carol L S, Fairooz P M,Sara E L, et al.Intra-arterial chemotherapy for retinoblastoma in 70 eyes[J]Ophthalmology,2014,121(7):1453-1460. [5] Stergios Z, David H A,Ira J D. More aggressive bone marrow screening in retinoblastoma patient is not indicated: the memorial sloan-kettering cancer center experience[J].Pediatr Blood Cancer,2006,46(1):56-61. [6] 王一卓,黄东生,史季桐,等. 骨髓细胞学检查在视网膜母细胞瘤中的应用价值[J].临床儿科杂志,2011,29(3):273-275. [7] Murphree A L.Intraocular retinoblastoma:the case for a new group classification[J].Ophthalmol Clin North AM,2005,8(1):41-53. [8] Dimaras H,Kimani K,Gallie B L,et al.Retinoblastoma[J].Lancet,2012,379(9824):1436-1446. [9] Hans E G. Retinoblastoma. Fifty Years of Progress. The LXXI edward jackson memorial lecture[J]. Ophthalmology,2014,58(5):875-891. [10] de Jong MC,de Graaf P, Noij DP, et al.Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma[J].Ophthalmology,2014,121(5):1109-1118. [11] 白晶,初冬,高海,等. miR-26a在Y79视网膜母细胞瘤细胞系内下调抑癌基因Rb1表达[J]. 首都医科大学学报,2014,35(4):473-476. [12] 张坚. EphB4和EphrinB2蛋白在视网膜母细胞瘤中的表达及其意义[J]. 解放军医药杂志,2015,27(8):25-28. |